These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 11460483

  • 1. Inhibition of fibrinolysis by lipoprotein(a).
    Anglés-Cano E, de la Peña Díaz A, Loyau S.
    Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
    [Abstract] [Full Text] [Related]

  • 2. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
    Anglés-Cano E, Rojas G.
    Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826
    [Abstract] [Full Text] [Related]

  • 3. Lipoprotein Lp(a) and atherothrombotic disease.
    de la Peña-Díaz A, Izaguirre-Avila R, Anglés-Cano E.
    Arch Med Res; 2000 Jan; 31(4):353-9. PubMed ID: 11068075
    [Abstract] [Full Text] [Related]

  • 4. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.
    Kang C, Dominguez M, Loyau S, Miyata T, Durlach V, Anglés-Cano E.
    Arterioscler Thromb Vasc Biol; 2002 Jul 01; 22(7):1232-8. PubMed ID: 12117743
    [Abstract] [Full Text] [Related]

  • 5. Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator.
    Anglés-Cano E, Hervio L, Rouy D, Fournier C, Chapman JM, Laplaud M, Koschinsky ML.
    Chem Phys Lipids; 1994 Jan 01; 67-68():369-80. PubMed ID: 8187237
    [Abstract] [Full Text] [Related]

  • 6. Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?
    Hervio L, Chapman MJ, Thillet J, Loyau S, Anglés-Cano E.
    Blood; 1993 Jul 15; 82(2):392-7. PubMed ID: 8329699
    [Abstract] [Full Text] [Related]

  • 7. In vitro inhibition of fibrinolysis by apolipoprotein(a) and lipoprotein(a) is size- and concentration-dependent.
    Knapp JP, Herrmann W.
    Clin Chem Lab Med; 2004 Jul 15; 42(9):1013-9. PubMed ID: 15497466
    [Abstract] [Full Text] [Related]

  • 8. Lipoprotein(a) isoforms display differences in affinity for plasminogen-like binding to human mononuclear cells.
    Kang C, Durlach V, Soulat T, Fournier C, Anglés-Cano E.
    Arterioscler Thromb Vasc Biol; 1997 Oct 15; 17(10):2036-43. PubMed ID: 9351369
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces.
    Hancock MA, Boffa MB, Marcovina SM, Nesheim ME, Koschinsky ML.
    J Biol Chem; 2003 Jun 27; 278(26):23260-9. PubMed ID: 12697748
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanism for the homocysteine-enhanced antifibrinolytic potential of lipoprotein(a) in human plasma.
    Nardulli M, Durlach V, Pepe G, Anglés-Cano E.
    Thromb Haemost; 2005 Jul 27; 94(1):75-81. PubMed ID: 16113787
    [Abstract] [Full Text] [Related]

  • 12. Overview on fibrinolysis: plasminogen activation pathways on fibrin and cell surfaces.
    Anglés-Cano E.
    Chem Phys Lipids; 1994 Jan 27; 67-68():353-62. PubMed ID: 8187235
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments.
    Rouy D, Koschinsky ML, Fleury V, Chapman J, Anglés-Cano E.
    Biochemistry; 1992 Jul 14; 31(27):6333-9. PubMed ID: 1627572
    [Abstract] [Full Text] [Related]

  • 14. Multiple binding with identical linkage: a mechanism that explains the effect of lipoprotein(a) on fibrinolysis.
    Hervio L, Durlach V, Girard-Globa A, Anglés-Cano E.
    Biochemistry; 1995 Oct 17; 34(41):13353-8. PubMed ID: 7577920
    [Abstract] [Full Text] [Related]

  • 15. Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding.
    Rahman MN, Petrounevitch V, Jia Z, Koschinsky ML.
    Protein Eng; 2001 Jun 17; 14(6):427-38. PubMed ID: 11477223
    [Abstract] [Full Text] [Related]

  • 16. Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57 --> Asn mutation in kringle IV-10 is associated with poor fibrin binding.
    Chenivesse X, Huby T, Wickins J, Chapman J, Thillet J.
    Biochemistry; 1998 May 19; 37(20):7213-23. PubMed ID: 9585533
    [Abstract] [Full Text] [Related]

  • 17. [Lipoprotein(a): a link between thrombogenesis and atherogenesis].
    Vucković B, Derić M.
    Med Pregl; 2007 May 19; 60(1-2):37-41. PubMed ID: 17853709
    [Abstract] [Full Text] [Related]

  • 18. The antifibrinolytic effect of lipoprotein(a) in heterozygous subjects is modulated by the relative concentration of each of the apolipoprotein(a) isoforms and their affinity for fibrin.
    Hervio L, Girard-Globa A, Durlach V, Anglés-Cano E.
    Eur J Clin Invest; 1996 May 19; 26(5):411-7. PubMed ID: 8796369
    [Abstract] [Full Text] [Related]

  • 19. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process.
    Anglés-Cano E.
    Braz J Med Biol Res; 1997 Nov 19; 30(11):1271-80. PubMed ID: 9532233
    [Abstract] [Full Text] [Related]

  • 20. Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu.
    Rouy D, Grailhe P, Nigon F, Chapman J, Anglés-Cano E.
    Arterioscler Thromb; 1991 Nov 19; 11(3):629-38. PubMed ID: 1827591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.